Source: Annual Congress 2009 - Next generation bronchodilators
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Tashkin, E. Kleerup, E. Heyman, D. Norris, S. Petruzzelli (Los Angeles, Rockville, United States Of America; Parma, Italy). Effect of carmoterol PMDI on 24-hour FEV₁ in COPD patients. Eur Respir J 2009; 34: Suppl. 53, 4346

Member's Comments

No comment yet.

Related content which might interest you: Effect of long-acting muscarinic antagonist (LAMA) on 24-hour physical behaviours in COPD Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020 Heliox administration in patients with COPD exacerbation – Technical aspects Source: Annual Congress 2010 - Mechanical ventilation and weaning Year: 2010 Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Effects of high dose N-acetylcysteine in COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Effects of acute dual bronchodilator treatment (tiotropium + olodaterol) on cardiopulmonary interactions in hyperinflated patients with COPD Source: International Congress 2018 – Advances in exercise physiopathology Year: 2018 Effect of roflumilast on hospitalizations in COPD patients Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 245s Year: 2001 Effect of tiotropium on exhaled breath temperature in patients with COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Effect of the once-daily long-acting bronchodilator combination umeclidinium/vilanterol (UMEC/VI) and bronchodilator monotherapy on dyspnoea as measured by the transitional dyspnoea index (TDI) in COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Effect of indacaterol maleate on dynamic lung hyperinflation in patients with COPD Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009 Effect of oxolamine on cough sensitivity in asthma patients Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003 Efficacy of tiotropium bromide inhalation combined with or without low dose theophylline for moderate to severe stable Chinese COPD patients Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Dose-related efficacy of vilanterol trifenatate (VI), a long-acting beta2 agonist (LABA) with inherent 24-hour activity, in patients with persistent asthma Source: Annual Congress 2010 - Bronchodilators in airways disease Year: 2010 Repeated-dose pharmacokinetics of once-daily TD-4208, a long-acting muscarinic receptor antagonist (LAMA), in subjects with COPD Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline Source: International Congress 2018 – COPD management Year: 2018 Effects of tiotropium bromide and fluticasone propionate/salmeterol on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Effect of olodaterol once-daily on heart rate in GOLD 2–4 COPD patients Source: International Congress 2017 – COPD management Year: 2017 Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006 Effect of formoterol alone and in combination with aclidinium on electrocardiograms in dogs Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012